Webinar: Ongoing/Continued Process Verification - How to Implement it in Small and Medium-sized Companies

Wednesday, 3 June 2020 14.00 - 16.00 h

Course No. 18013

header-image

Important: Deadline is 12 noon on 02 June 2020

Background

With the change of FDA´s process validation guideline from 1987 and the Annex 15 of EU GMP Guide, a validation life cycle entered the validation world. The development, the validation of the manufacturing process/ Process Performance Qualification (PPQ) and the Ongoing/Continued Process Verification are now the current validation stages. Especially the requirement for a stage 3 is a challenge for enterprises as this stage is new and did not exist before the validation life cycle. The Ongoing/Continued Process Verification will substitute revalidation in most cases. It supplements the Product Quality Review (PQR) or Annual Product Review (APR), which is usually written in the USA every year. The FDA Process Validation Guidance requires statistically sounded data evaluated from a statistically trained person.  Both in Europa and in the USA, this stage 3 is intended to show that the process is in “control of state”. This applies to the single batches (intra-batch-variabilities) and to the comparison of single batches with each other (inter-batch-variabilities).This gives rise to a number of questions. Which data of a manufacturing process should be evaluated in an Ongoing/Continued Process Verification according to a rationale? How is the statistical sampling in this context? What statistical indicators are required? How can the requirements be implemented in small and medium-sized companies in a pragmatic way?

Target Group

Employees from companies, who are involved in pharmaceutical process validation activities (developers, QM, manufacturing, heads of validation departments, etc.) especially regarding stage 3 ongoing/continued process verification, are addressed. Of course consultants in this field, who want to get information from the view of the medicinal product manufacturers, are addressed too

Technical Requirements

For our webinars, we use Cisco WebEx, one of the leading suppliers of online meetings.

At http://www.webex.com/test-meeting.html you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in.  Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.

Programme

The following issues will be discussed:
  • The Validation Life Cycle – FDA and Annex 15 requirements
  • Specific characteristics of stage 3 Ongoing/Continued Process Verification
  • What data have to be monitored?
  • How to set up a statistical sampling plan?
  • Statistical indicators for stage 3
  • Proposals for implementaton for small and medium-sized enterprises
  • Examples of FDA findings (Warning Letters)

ECA-Member*: € 199,-
Non ECA Member*: € 249,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Additional dates on-site
Additional dates on-site
not available
icon
Additional dates online
Additional dates online
not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

"I am so grateful for having attended this course. Great job from all, and very profitable. Thanks!”

Alba Aranda Cuesta, Kern Pharma
KPIs and Quality Metrics, Berlin, Germany, April 2025

"The lectures were very informative, interesting and entertaining."

Albert Godoy Hernández, Company synaffix
Live Online Training - GMP Auditor Practice, October 2024

"Really useful training which I will use in my daily work."

Regina Mommaerts, Galapagos NV
Live Online Training - GMP Auditor Practice, October 2024

"Wonderful format of the sessions: Good range of participations and experience in the team. Would love to attend another one soon."

Roopasi Mathi, Wacker Biotech B.V.
Live Online Training - GMP Auditor Practice, October 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Both, organizers and lecturers were very friendly, open for discussions and extremely constructive. The course was a valuable experience for me.”

Maria Dimitrova, NKN Law Firm
Pharmaceutical Contracts: GMP and Legal Compliance, March 2025